A targeted drug-repurposing strategy identifies Tavaborole (Kerydin) as a potent fungistatic agent against Candida auris
This study employs a targeted drug-repurposing strategy to identify the FDA-approved antifungal Tavaborole as a potent agent against multidrug-resistant *Candida auris* across all major clades and elucidates the pathogen's distinct adaptive resistance mechanisms through integrated proteomic and ultrastructural analyses.